Kenneth Ssebambulidde
Kenneth Ssebambulidde publishes mostly in Epidemiology, Infectious Diseases and Surgery, on topics such as Fungal Infections and Studies, Infectious Diseases and Tuberculosis and Antifungal resistance and susceptibility.
- World rank
- #868,133 of 7,710,434 ranked researchers
- Rank in Uganda
- #414 of 3,724
- Works
- 98
- Citations
- 2k
- Citations per work
- 20.6
What does Kenneth Ssebambulidde research?
Kenneth Ssebambulidde's work is mostly in Medicine (70%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6869.7%
- Medicine6869.7%
- Everything else2323.2%
- Life Sciences77.1%
- 1Epidemiology34% of their works
- 2Infectious Diseases18% of their works
- 3Surgery16% of their works
- 4Microbiology4% of their works
- 5Immunology3% of their works
- 6Public Health, Environmental and Occupational Health3% of their works
Research topics
- Fungal Infections and Studies
- Infectious Diseases and Tuberculosis
- Antifungal resistance and susceptibility
- Nail Diseases and Treatments
- Bacterial Infections and Vaccines
- Tuberculosis Research and Epidemiology
- Cytomegalovirus and herpesvirus research
- Pneumocystis jirovecii pneumonia detection and treatment
Which keywords describe Kenneth Ssebambulidde's research?
The keywords of their largest research topics: Antifungal Therapy, Epidemiology, Cryptococcal Disease, Histoplasmosis, Antiretroviral Therapy, Diagnosis, Immunocompromised Patients and Spinal Epidural Abscess.
- Pneumocystis
- Cytomegalovirus
- Mycobacterium tuberculosis
- Bacterial Meningitis
- Vaccine
- Dermatophytes
- Candidiasis
- Spinal Epidural Abscess
- Diagnosis
- Histoplasmosis
- Epidemiology
- Antifungal Therapy
- Cryptococcal Disease
- Antiretroviral Therapy
- Immunocompromised Patients
- Tuberculous Meningitis
- Invasive Fungal Infections
- Onychomycosis
- Treatment
- Neisseria meningitidis
- Tuberculosis
- Infection
- Pneumonia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Antifungal Therapy1003 topics
- Epidemiology775 topics
- Cryptococcal Disease501 topic
- Histoplasmosis501 topic
- Antiretroviral Therapy392 topics
- Diagnosis383 topics
- Immunocompromised Patients342 topics
- Spinal Epidural Abscess331 topic
- Tuberculous Meningitis331 topic
- Candidiasis281 topic
- Invasive Fungal Infections281 topic
- Dermatophytes221 topic
- Onychomycosis221 topic
- Vaccine212 topics
- Treatment162 topics
- Bacterial Meningitis111 topic
- Neisseria meningitidis111 topic
- Mycobacterium tuberculosis101 topic
- Tuberculosis101 topic
- Cytomegalovirus81 topic
- Infection81 topic
- Pneumocystis61 topic
- Pneumonia61 topic
Where does Kenneth Ssebambulidde work?
Kenneth Ssebambulidde's main affiliation in the publication record is Makerere University, Uganda.
How many publications and citations does Kenneth Ssebambulidde have?
OpenAlex counts 98 works and 2,021 citations for Kenneth Ssebambulidde, an h-index of 25, ranking #868,133 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kenneth Ssebambulidde. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.